Status
Conditions
Treatments
About
Comparison of safety and long-term effects of BioMimeTM stent and Ultimaster® stent with Xience® stent
Full description
A prospective, open, multicenter, and observational study will register and compare Xience® groups treated in institutions such as the BioMime ™, Ultimaster® group prospectively registered from June 2016.
The Xience® group has already been registered in the previous study (SMARTDESK-BX), so BioMimeTM and Ultimaster® only need to be registered. Follow-up will be conducted until December 2019, and e-CRF will be completed by April 2020.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
2,000 participants in 2 patient groups
Loading...
Central trial contact
Taek Kyu Park; Hyeon Cheol Gwon
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal